DCGI asks Serum Institute to revise protocol for phase 2, 3 trials of Oxford COVID-19 vaccine
The panel also recommended that the proposed clinical trial sites be distributed across India, the source said.
Full Article
DCGI asks Serum Institute to revise protocol for phase 2, 3 trials of Oxford COVID-19 vaccine
Hindu
0 shares
1 views
You might like
Related news coverage
Panel recommends permission to Serum Institute for phase 2, 3 human clinical trials of Oxford vaccine candidate
IndiaTimes
A subject expert committee on Covid-19 on Friday recommended to the country's drug regulator that permission be granted to Serum..
-
India readies five sites for final phase of human trials of Oxford COVID vaccine
Mid-Day
-
Serum Institute of India seeks DCGI permission for phase 2/3 clinical trials of Oxford’s COVID-19 vaccine
Hindu
-
Adar Poonawalla: I believe Oxford coronavirus vaccine Covishield will reach masses by 2021 first quarter of
Mid-Day
-
Serum Institute has begun manufacturing Oxford coronavirus vaccine
Hindu
Advertisement
More coverage
Support grows for deliberately exposing vaccine trial subjects to COVID-19, with Oxford team leading the way
It began as a proposal on the fringes of science: deliberately exposing people to COVID-19 to speed up development of vaccines,..
National Post
COVID-19 vaccine: Scientists strike note of caution as 'Made in India' vaccine programme gains momentum
New Delhi: India's COVID-19 vaccine programme has gained sudden traction but it is imperative to strike a balance between giving it..
Mid-Day